← Back to Search

Sensor

MicroTrend System for Low Blood Flow

N/A
Waitlist Available
Led By Raul J Gazmuri, MD, PhD
Research Sponsored by ExoStat Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a device called the MicroTrend System, which measures carbon dioxide levels in the mouth. It is aimed at hospital patients to help doctors monitor their breathing and overall health. The study will check if this device is safe and effective.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-6 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Correlation between POMCO2

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MicroTrend SystemExperimental Treatment1 Intervention
MicroTrend System is placed onto the subject's cheek and the subject will actively participate in the study for up to 6 hours, with up to 4 hours of sensor monitoring.

Find a Location

Who is running the clinical trial?

ExoStat Medical, Inc.Lead Sponsor
Bright Research PartnersIndustry Sponsor
17 Previous Clinical Trials
2,647 Total Patients Enrolled
Raul J Gazmuri, MD, PhDPrincipal InvestigatorCaptain James A. Lovell Federal Health Care Center
~2 spots leftby Nov 2025